Moon Surgical raises $31.3M for robotic surgery system

Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system.

GT Healthcare Capital & Partners led the round. There was also participation from  Johnson & Johnson Innovation – JJDC, Cathay Health — and existing investors including Sofinnova Partners and medtech leaders including Yann Fleureau, Siddarth Satish, Sacha Loiseau and Richard Leparmentier.

“At Moon Surgical, our ambition is to revolutionize minimally invasive surgery through the power of collaborative and adaptive robotics. Our Maestro System can be used in any laparoscopy, in any operating room,” said Anne Osdoit, CEO of Moon Surgical and a partner in Sofinnova Partners’ medtech accelerator, MD Start.

“We are excited to work with our new partners at GT Healthcare, Johnson & Johnson, and Cathay Health as we enter the ne…

Read more
  • 0

Ethicon launches next-gen surgical stapler

The next-gen Echelon 3000 surgical stapler [Image courtesy of Johnson & Johnson’s Ethicon]Johnson & Johnson’s Ethicon today announced the U.S. launch of its next-gen Echelon 3000 stapler.

The Echelon 3000 is digitally-enabled and provides surgeons with simple, one-handed powered articulation, according to the Johnson & Johnson (NYSE:JNJ) company.

The surgical stapler’s creators designed it with 39% greater jaw aperture and a 27% greater articulation span. The idea was to give surgeons better access and control over each transection. The software then provides real-time haptic and audible device feedback so that surgeons can make critical adjustments during procedures.

“Surgical complications often stem from difficult-to-access anatomy and compromised tissue, which this next generation Echelon stapler is specifically designed to address,” said Tom O’Brien, worldwide president of Endomechanical at Ethicon.

<…
Read more
  • 0

FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty

Johnson & Johnson MedTech’s DePuy Synthes ortho device company announced today that its Inhance system has received FDA clearance for total shoulder arthroplasty.

DePuy Synthes officials say their company is first to market with a fully convertible should arthroplasty system. The new clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty and provides surgeons with interoperative flexibility.

The reverse system’s features include:

A 135° neck-shaft angle with lateralized options; A variety of sizing options; 3D laser-printed R/SPEED baseplates and modular Baseplates with central screw and central post options Advanced cross-linked Vitamin E polyethylene for desired wear characteristics and oxidative stability One Step Prep glenoid reamers

“The Inhance shoulder system can be used for an anatomic or reverse shoulder procedure offering the surgeon and OR staff a streamlined and effective shoulder syst…

Read more
  • 0

Johnson & Johnson’s Consumer Health chief to run new stand-alone company

Thibaut Mongon — EVP and Worldwide Chair of Consumer Health at Johnson & Johnson since 2019 — will be CEO of the business when it spins out as a stand-alone company.

J&J (NYSE: JNJ) expects the spinoff to be complete in 2023, subject to legal requirements, including consultation with works councils and employee representatives.

“Thibaut is a visionary and respected global leader, whose consumer-centric mindset has repeatedly propelled the business forward. Under his leadership, the Consumer Health business of Johnson & Johnson has advanced its innovation to reach consumers with products that truly make a difference in their personal health, while simultaneously delivering healthy financial results,” Executive Chair Alex Gorsky said in a news release.

 

Read more
  • 0

Emergent hid quality problems from FDA, House report concludes

A new Congressional report concluded that Emergent BioSolutions (NYSE:EBS) attempted to hide evidence related to quality problems before informing the FDA that 15 million COVID-19 vaccines were contaminated.

Prepared for Rep. Carolyn Maloney (D-NY) and James E. Clyburn (D-SC), the report from the House and the Select Subcommittee on the Coronavirus Crisis scrutinizes the quality controls in Emergent’s Bayview plant in Baltimore.

In particular, the House report concluded that Emergent workers removed quality-assurance “hold” tags from Johnson & Johnson vaccine batches before an FDA inspection.

The Bayview plant had served as the only U.S. manufacturing site for the J&J COVID-19 vaccine.

The report relies on internal communications from Emergent executives to determine whether the company attempted to elude government oversight.

It also noted that the FDA, J&J and AstraZeneca employees identified problems at the …

Read more
  • 0

Johnson & Johnson MedTech appoints new CFO

Johnson & Johnson MedTech (NYSE:JNJ) announced that Kurt Van den Bosch has been appointed as its CFO, group finance.

Van den Bosch will be a member of Johnson & Johnson’s global finance team, reporting to the company’s EVP and CFO Joe Wolk. Van den Bosch’s role includes providing financial leadership to the global Johnson & Johnson MedTech organization.

He most recently served as area VP of mid-sized markets for J&J MedTech EMEA, overseeing the EMEA business that included the markets of Austria, Belgium, Greece, Israel, Portugal, Switzerland, the Netherlands and Scandinavian countries.

Van den Bosch joined Johnson & Johnson’s Janssen Pharmaceuticals, Belgium, company in 1990 as part of its finance team and has held a range of roles with increasing responsibility since. Before joining J&J MedTech, he was CFO for Janssen EMEA from 2012 to 2014, before being appointed to the role of CFO for global surgery EMEA…

Read more
  • 0

The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain

[Illustration via Adobe Stock] Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships.

If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare.

The challenge has long been how to capture that information, store it, analyze it and deploy it to improve medical product design, manufacturing and the health of patients.

Then came the cloud, and with it a host of acronyms: software as a service (SaaS), platform as a service (PaaS), infrastructure as a service (IaaS), and — following the same convention — software as a medical device (SaMD).

Over the past few months, Medical Design & Outsourcing connected with leaders in medtech and cloud computing, including the three largest providers of cloud computing services: Amazon (Nasdaq: AMZN), Microsoft (Nasdaq: MSFT) and Google (Nasdaq: GOOGL).…

Read more
  • 0

The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain

[Illustration via Adobe Stock]

Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships.

If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare.

The challenge has long been how to capture that information, store it, analyze it and deploy it to improve medical product design, manufacturing and the health of patients.

Then came the cloud, and with it a host of acronyms: software as a service (SaaS), platform as a service (PaaS), infrastructure as a service (IaaS), and — following the same convention — software as a medical device (SaMD).

Over the past few months, Medical Design & Outsourcing connected with leaders in medtech and cloud computing, including the three largest providers of cloud computing services: Amazon (Nasda…

Read more
  • 0

May 2022 Issue: The cloud is transforming medtech

 

The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain

How DeepWell is developing video games as tools for treating medical conditions

Digital therapeutics open up new opportunities in medicine

Harnessing the power of cloud computing

When Johnson & Johnson and Microsoft announced a deal earlier this year to use cloud computing to support digital surgery, executives on both sides spoke with Medical Design & Outsourcing about how the partnership could advance medtech.

That started a series of conversations with leaders at cloud computing giants Google, Microsoft and Amazon — and on the device side at Johnson & Johnson, Philips and GE Healthcare. We consistently heard that the COVID-19 pandemic accelerated cloud adoption not only for medical records and telehealth, but also for manufacturing operations, supply chain management and making new vaccines, therapies and d…

Read more
  • 0

Manufacturing matchmaker Fictiv raises $100M for supply chain push

Fictiv co-founder and CEO Dave Evans [Photo courtesy of Fictiv]Fictiv has closed a $100 million Series E funding round, the on-demand manufacturing technology company said today.

Fictiv focuses on “helping companies produce better products,” co-founder and CEO Dave Evans said, with three main offerings: new product development, engineer-to-order products, and maintenance, repair and operations (MRO).

But the company doesn’t actually own any manufacturing equipment, and instead has built a vetted network of 250 manufacturing partners, Evans told DeviceTalks Editorial Director Tom Salemi in an interview. After medical device developers upload their designs to Fictiv’s web-based platform, they get instant pricing and help choosing from different manufacturing methods, standards and prices to find the best fit.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Manufacturing matchmaker Fictiv raises $100M for supply chain push

Fictiv co-founder and CEO Dave Evans [Photo courtesy of Fictiv]

Fictiv has closed a $100 million Series E funding round, the on-demand manufacturing technology company said today.

Fictiv focuses on “helping companies produce better products,” co-founder and CEO Dave Evans said, with three main offerings: new product development, engineer-to-order products, and maintenance, repair and operations (MRO).

But the company doesn’t actually own any manufacturing equipment, and instead has built a vetted network of 250 manufacturing partners, Evans told Device Talks Editorial Director Tom Salemi in an interview. After medical device developers upload their designs to Fictiv’s web-based platform, they get instant pricing and help choosing from different manufacturing methods, standards and prices to find the best fit.

“I’m the go-between [with contract manufacturers] bec…

Read more
  • 0

Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens

[Image from Johnson & Johnson Vision]Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards.

The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 hours without the need for allergy drops while also providing vision correction, received FDA approval in March.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0